This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tiev, K. P. Articles by Cabane, J. Search for Related Content PubMed PubMed Citation Articles by Tiev, K. P. Articles by Cabane, J.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, March 2003, p. 315-316, Vol. 10, No. 2
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.2.315-316.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

RNase L Levels in Peripheral Blood Mononuclear Cells: 37-Kilodalton/83-Kilodalton Isoform Ratio Is a Potential Test for Chronic Fatigue Syndrome

Kiet Phong Tiev,^1* Edith Demettre,² Philippe Ercolano,¹ Lionel Bastide,² Bernard Lebleu,² and Jean Cabane¹

Service de Médecine Interne, Hôpital Saint Antoine, 75571 Paris Cedex 12,¹ UMR 5124 CNRS, Université Montpellier 2, 34293 Montpellier Cedex 5, France²

Received 17 May 2002/ Returned for modification 26 September 2002/ Accepted 30 December 2002

Chronic fatigue syndrome (CFS) is a disorder characterized by debilitating fatigue associated with immunological abnormalities. The etiology remains unclear. A low-molecular-mass (37 kDa) isoform of RNase L has been described in peripheral blood mononuclear cell (PBMC) extracts, and the ratio of two isoforms of RNase L (37 kDa/83 kDa) has been proposed as a potential biochemical marker of CFS. In a prospective case-control study, we tested whether the RNase L 37-kDa/83-kDa ratio could discriminate a SFC population. We compared the ratio of RNase L isoforms in PBMCs from 11 patients with CFS (6 women and 5 men; mean age ± standard deviation, 43.2 ± 13.8 years) and PBMCs from 14 healthy well-matched volunteers (10 women and 4 men; age, 39.1 ± 11.6 years). A ratio of RNase L of 0.4 used as a threshold allowed diagnosis of CFS with high sensitivity (91%; 95% confidence interval [CI], 57 to 99%) and specificity (71%; 95% CI, 41 to 90%). The positive and negative prognostic values were 71% (95% CI, 41 to 90%) and 91% (95% CI, 57 to 99%), respectively. In the absence of acute infection or chronic inflammation, a high RNase L ratio could distinguish CFS patients from healthy volunteers. Additional large studies and follow-up studies are required to confirm the stability of this high ratio of RNase L isoforms in a CFS group.

---

* Corresponding author. Mailing address: Service de Médecine Interne, Hôpital Saint Antoine, 184 Rue du Faubourg Saint Antoine, 75571 Paris Cedex 12, France. Phone: 33 (1) 49 28 30 54. Fax: 33 (1) 1 49 29 28 85. E-mail: kiet.tiev{at}sat.ap-hop-paris.fr.

---

Clinical and Diagnostic Laboratory Immunology, March 2003, p. 315-316, Vol. 10, No. 2
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.2.315-316.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Fremont, M., Vaeyens, F., Herst, C. V., De Meirleir, K., Englebienne, P., Tiev, K. P., Cabane, J., Lebleu, B. (2005). 37-Kilodalton/83-Kilodalton RNase L Isoform Ratio in Peripheral Blood Mononuclear Cells: Analytical Performance and Relevance for Chronic Fatigue Syndrome. CVI 12: 1259-1260 [Full Text]  
• Tiev, K. P., Briant, M., Ziani, M., Cabane, J., Demettre, E., Lebleu, B. (2005). Variability of the RNase L Isoform Ratio (37 Kilodaltons/83 Kilodaltons) in Diagnosis of Chronic Fatigue Syndrome. CVI 12: 366-366 [Full Text]